Asterus Spółka z Ograniczoną Odpowiedzialnością (KRS 0000696161, NIP 6772425530) is a Polish company, headquartered in Kraków, Małopolskie voivodeship. ASTERUS operates in: Wholesale of pharmaceutical goods (PKD 46.46.Z). Industry: Wholesale trade. The company has been listed in the National Court Register since September 21, 2017. ASTERUS's most recently reported net revenue was 3.1 M PLN for 2023.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Asterus
Identity
- Name
- Asterus Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- September 21, 2017
- Registry status as of
- July 6, 2026
- Latest entry
- July 6, 2026
- Founding act
- 20.09.2017R.
Articles of association history (1)
- September 20, 2017: 20.09.2017R.
Activities
Main activity
46.46.ZWholesale of pharmaceutical goods
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. SAMUELA BOGUMIŁA LINDEGO, 1C, 30-148, KRAKÓW, POLSKA
- Voivodeship
- MAŁOPOLSKIE
- District
- KRAKÓW
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
Risk and payment profile - Asterus
Credibility rating
81.8 / 100
Very good credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
1
1/9 yrs
Board changes
1
1/9 yrs
PKD changes
1
1/9 yrs
Name changes
0
0/9 yrs
Data from 9 years of registry activity.
Credibility history
Payment reliability score from 2018–2023
Current: B (82/100)
Trend: deteriorating (-2.3 pts/year)
High payment credibility - the company's financial condition is good and the risk of cooperating with it is low.
Trade credit limit history
Standard limit from 2018–2023
Current: 502.4 K PLN
Safe: 305.9 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Asterus
Founded
September 21, 2017
8 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
KRAKÓW
MAŁOPOLSKIE
Primary PKD
46.46.Z
Wholesale of pharmaceutical goods
Share capital
5.0 K PLN
95 shares total
Shareholders
1
shareholder
Board
1 person
Filed years
6 years
2018–2023
Registry entries
26
latest: July 6, 2026
Revenue
3.1 M PLN
2023
Net profit
311.1 K PLN
2023
Assets
3.2 M PLN
2023
Equity
3.2 M PLN
2023
EBITDA
N/A
2023
no depreciation data
Valuation
1.7 M PLN
High confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Asterus.
No ratings
Related articles
Explainer
Eurocash in 2026: Polish FMCG-wholesale leader and Delikatesy Centrum network, an mWIG40 issuer near Poznań, controlled by Luis Amaral
Eurocash S.A. (KRS 0000213765), headquartered at ul. Wiśniowa 11 in Komorniki near Poznań, is the leader of Poland's FMCG-wholesale distribution and the operator of the 1,500+ Delikatesy Centrum store network. Founded in 1995 by Portuguese entrepreneur Luis Amaral, listed on the WSE since 2005, the company is an mWIG40 constituent. A six-member management board, a five-member supervisory board, chaired by the founder himself.
Explainer
Mercator Medical in 2026: a Kraków-based medical-glove producer with plants in Thailand, an mWIG40 issuer after the COVID meme-stock cycle
Mercator Medical S.A. (KRS 0000036244), headquartered at ul. Modrzejewskiej 30 in Kraków, is a Polish producer and distributor of single-use medical gloves (nitrile and latex) and other disposables. The company controls the full value chain: plants in Thailand (Mercator Medical Thailand) plus Polish and international distribution. In 2020 the share price exploded on pandemic demand (from PLN 10 to over PLN 800), followed by cautious normalisation. Listed on the WSE since 2013. A three-member management board, a five-member supervisory board.
